[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20030316L - Virkning av forskjellige CHO eller blanding på fekale bifidobakterier hos mennesker - Google Patents

Virkning av forskjellige CHO eller blanding på fekale bifidobakterier hos mennesker

Info

Publication number
NO20030316L
NO20030316L NO20030316A NO20030316A NO20030316L NO 20030316 L NO20030316 L NO 20030316L NO 20030316 A NO20030316 A NO 20030316A NO 20030316 A NO20030316 A NO 20030316A NO 20030316 L NO20030316 L NO 20030316L
Authority
NO
Norway
Prior art keywords
composition
humans
mixture
effect
infection
Prior art date
Application number
NO20030316A
Other languages
English (en)
Other versions
NO20030316D0 (no
Inventor
Florence Rochat
Olivier Ballevre
Alfred Jann
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of NO20030316D0 publication Critical patent/NO20030316D0/no
Publication of NO20030316L publication Critical patent/NO20030316L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/25—Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Grain Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
NO20030316A 2000-07-24 2003-01-21 Virkning av forskjellige CHO eller blanding på fekale bifidobakterier hos mennesker NO20030316L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00115850A EP1175905A1 (en) 2000-07-24 2000-07-24 Nutritional Composition
PCT/EP2001/008283 WO2002007533A2 (en) 2000-07-24 2001-07-17 Nutritional composition

Publications (2)

Publication Number Publication Date
NO20030316D0 NO20030316D0 (no) 2003-01-21
NO20030316L true NO20030316L (no) 2003-03-14

Family

ID=8169332

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030316A NO20030316L (no) 2000-07-24 2003-01-21 Virkning av forskjellige CHO eller blanding på fekale bifidobakterier hos mennesker

Country Status (22)

Country Link
US (2) US20030166610A1 (no)
EP (4) EP1175905A1 (no)
JP (1) JP4955896B2 (no)
KR (1) KR20030041962A (no)
CN (1) CN100349575C (no)
AT (1) ATE485827T1 (no)
AU (1) AU2001289680A1 (no)
BG (1) BG107473A (no)
BR (2) BRPI0112685B1 (no)
CA (1) CA2416990C (no)
CZ (1) CZ2003535A3 (no)
DE (1) DE60143356D1 (no)
DK (1) DK1305036T3 (no)
ES (2) ES2355754T3 (no)
HU (1) HUP0303728A3 (no)
IL (1) IL153989A (no)
MX (1) MXPA03000742A (no)
NO (1) NO20030316L (no)
PL (1) PL366049A1 (no)
PT (1) PT1305036E (no)
WO (1) WO2002007533A2 (no)
ZA (1) ZA200301401B (no)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2815824B1 (fr) * 2000-10-31 2003-04-25 Colloides Naturels Internat Methode et preparation de type fibre alimentaire soluble bifidogene pour la mise en oeuvre de ladite methode
WO2003015533A1 (en) 2001-08-20 2003-02-27 K.U. Leuven Research And Development Non-starch-polysaccharides
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
FR2848783B1 (fr) * 2002-12-18 2005-05-13 Agronomique Inst Nat Rech Utilisation de prebiotiques pour prevenir ou traiter le stress oxydant
PL2368553T3 (pl) 2003-04-08 2015-05-29 Progenics Pharm Inc Preparaty farmaceutyczne zawierające metylonaltrekson
PT1675481E (pt) * 2003-10-24 2009-01-02 Nutricia Nv Composição sinbiótica para bebés
NO320546B1 (no) * 2003-12-12 2005-12-19 Nova Biotics As Prebiotiske kombinasjonsprodukter
CA2548379C (en) * 2003-12-12 2012-03-13 Taiyo Kagaku Co., Ltd. Compositions of galactomannan for the treatment of bowel diseases
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
DK1855550T3 (da) * 2005-02-28 2012-01-16 Nutricia Nv Næringspræparat med probiotika
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
CN104248763A (zh) 2005-03-07 2014-12-31 芝加哥大学 阿片样物质拮抗剂用于减少内皮细胞增殖和迁移的用途
AR057325A1 (es) 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
GB2432772B (en) * 2005-11-30 2011-06-01 Sis Improvements in and relating to nutritional products
CA2945356C (en) 2007-03-29 2021-03-23 Progenics Pharmaceuticals, Inc. (r)-n-methylnaltrexone bromide and pharmaceutical compostitions therof useful as peripheral .mu. opioid receptor antagonist
EP2139890B1 (en) 2007-03-29 2014-06-25 Wyeth LLC Peripheral opioid receptor antagonists and uses thereof
TWI466671B (zh) 2007-03-29 2015-01-01 Progenics Pharm Inc 末梢性類鴉片受體拮抗劑及其用途
GB0718974D0 (en) 2007-09-28 2007-11-07 Univ Leuven Kath oligosaccharides derived from arabinoxylan for prevention of gastrointestinal infection
PL2234505T3 (pl) * 2007-12-21 2013-06-28 Nutricia Nv Zastosowanie sfingomieliny i nietrawionych węglowodanów do poprawy mikroflory jelitowej
JP5358587B2 (ja) 2008-02-06 2013-12-04 プロジェニックス・ファーマシューティカルス・インコーポレイテッド （ｒ），（ｒ）−２，２’−ビス−メチルナルトレキソンの製造及び用途
JP5647098B2 (ja) 2008-03-21 2014-12-24 ザ ユニヴァーシティー オヴ シカゴ オピオイド拮抗薬とｍＴＯＲ阻害薬を用いた治療
GB0805360D0 (en) 2008-03-25 2008-04-30 Univ Leuven Kath Arabinoxylan oligosaccharide preparation
EP2612562B1 (en) 2008-03-28 2015-01-28 Nestec S.A. Probiotics for use in expecting female mammals for enhancing the immunity of their offsprings
WO2010008272A1 (en) * 2008-07-15 2010-01-21 N.V. Nutricia Treatment of gut motility disorders
CA2676881C (en) 2008-09-30 2017-04-25 Wyeth Peripheral opioid receptor antagonists and uses thereof
SG10201901259RA (en) 2009-02-24 2019-03-28 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
IN2012DN03632A (no) * 2009-11-12 2015-06-26 Nestec Sa
EP2563372A4 (en) 2010-04-28 2013-10-02 Ritter Pharmaceuticals Inc PREBIOTIC FORMULATIONS AND METHODS OF USE
KR101421807B1 (ko) * 2012-09-28 2014-07-22 주식회사 포스코 코크스 오븐의 타르 제거장치
US20150296851A1 (en) * 2012-11-27 2015-10-22 Shanghai Jiao Tong University Compositions for Balancing Gut Microbiota and the Preparation and the Uses thereof
CN103704472B (zh) * 2013-12-13 2016-03-23 山东星光生物科技有限公司 一种低聚果糖功能性浓缩饲料及其制备方法
WO2015092056A1 (en) * 2013-12-20 2015-06-25 Nestec S.A. Nutritional compositions for reducing intestinal pathogens
CN104920809B (zh) * 2014-03-18 2018-02-23 中国科学院大连化学物理研究所 一种改善母猪奶水中乳汁寡糖的饲料添加剂预混剂及其使用方法
EP3151689A1 (en) * 2014-04-25 2017-04-12 Nexira International Use of a composition comprising arabic gum (ag) for improving gut impermeability
KR102538288B1 (ko) * 2014-10-03 2023-05-31 가부시키가이샤 메이지 올리고당 제제 및 그 제조 방법
CN104939082A (zh) * 2015-06-02 2015-09-30 西安膳方医药科技有限公司 一种复合益生元及其制备方法
EA035945B1 (ru) * 2015-08-04 2020-09-04 Зюдцукер АГ Профилактическое использование инулина от синусита
WO2017027601A1 (en) * 2015-08-11 2017-02-16 Shaklee Corporation Materials and methods for improving gastrointestinal health
WO2018132627A1 (en) * 2017-01-13 2018-07-19 Access Business Group International Llc Dietary prebiotic supplement for promoting the activity of amylolytic and short-chain fatty acid producing microbes
CN108902970A (zh) * 2018-06-27 2018-11-30 安徽瑞康食品生物科技有限公司 含有戊聚糖的食用组合物，功能食品及其制备方法、用途
CN109315728A (zh) * 2018-09-19 2019-02-12 北京爱仁医疗科技有限公司 一种含有虾青素的食品及其在肠道菌群调节中的应用
EP4231851A1 (en) * 2020-10-21 2023-08-30 Compagnie Gervais Danone Acacia gum for iron induced microbial dysbiosis
EP4418870A1 (en) * 2021-10-22 2024-08-28 Mars Incorporated Nucleotides and oligosaccharides for use as food composition
JP7513327B1 (ja) 2023-09-01 2024-07-09 株式会社feileB 固形製剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
US5827526A (en) * 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
DE69506095T2 (de) * 1995-08-04 1999-06-24 Naamloze Vennootschap Nutricia, Zoetermeer Diätfasern enthaltende Nahrungszusammensetzung
CA2198681C (en) * 1996-03-01 2004-10-26 Sherianne James Method for producing fat-free and low-fat viscous dressings using inulin
US5952033A (en) * 1996-12-24 1999-09-14 Nestec S.A. Gelatinized cereal product containing oligosaccharide and processes of preparing and using same
IT1304170B1 (it) * 1998-12-15 2001-03-08 Novartis Nutrition Ag Composti organici
JP4273277B2 (ja) * 1999-06-30 2009-06-03 大塚製薬株式会社 オリゴ糖補給組成物

Also Published As

Publication number Publication date
EP2204176A2 (en) 2010-07-07
KR20030041962A (ko) 2003-05-27
HUP0303728A2 (hu) 2004-03-29
AU2001289680A1 (en) 2002-02-05
CZ2003535A3 (cs) 2003-09-17
CA2416990A1 (en) 2002-01-31
BR0112685A (pt) 2003-06-24
HUP0303728A3 (en) 2004-12-28
CN1466459A (zh) 2004-01-07
ES2355754T3 (es) 2011-03-30
IL153989A (en) 2005-08-31
JP2004504332A (ja) 2004-02-12
BG107473A (bg) 2004-07-30
JP4955896B2 (ja) 2012-06-20
EP2255815B1 (en) 2017-10-25
WO2002007533A3 (en) 2002-04-11
CN100349575C (zh) 2007-11-21
BRPI0112685B1 (pt) 2020-04-07
NO20030316D0 (no) 2003-01-21
ATE485827T1 (de) 2010-11-15
WO2002007533A2 (en) 2002-01-31
EP2204176A3 (en) 2010-07-14
PT1305036E (pt) 2011-01-28
EP2255815A2 (en) 2010-12-01
US7141554B2 (en) 2006-11-28
DE60143356D1 (de) 2010-12-09
EP1305036B1 (en) 2010-10-27
US20050053641A1 (en) 2005-03-10
EP2255815A3 (en) 2012-07-11
CA2416990C (en) 2010-09-14
MXPA03000742A (es) 2003-09-25
DK1305036T3 (da) 2011-02-07
PL366049A1 (en) 2005-01-24
EP1305036A2 (en) 2003-05-02
US20030166610A1 (en) 2003-09-04
ES2650122T3 (es) 2018-01-17
ZA200301401B (en) 2004-05-21
IL153989A0 (en) 2003-07-31
EP1175905A1 (en) 2002-01-30

Similar Documents

Publication Publication Date Title
NO20030316D0 (no) Virkning av forskjellige CHO eller blanding på fekale bifidobakterier hos mennesker
BR0313185A (pt) Probióticos para funções neuromusculares intestinais
PT1395269E (pt) Ácido lipoteicóico de bactérias ácido-lácticas para utilização como medicamento e no tratamento de doenças bacterianas
NZ599302A (en) Preventing diseases in infants delivered via caesarean section
MXPA04005583A (es) Composicion para la promocion del crecimiento oseo y mantenimiento de la salud osea.
EA200300862A1 (ru) Связывание эндотоксина под действием лактобактерий и бифидобактерий
ATE329031T1 (de) Therapeutische zusammensetzungen zur behandlung von lawsonia intracellularis infektionen
ATE228001T1 (de) Pharmazeutische zusammensetzungen für medizinische und veterinäre verwendung zur verbesserung der darmflora bei dyspeptischem syndrom und diarrhoeen auf dem veterinärsektor
EP1393734A4 (en) DRUG AGAINST DARMER DISEASES
PT1181047E (pt) Composicao compreendendo esfingomielinase alcalina para utilizacao como preparacao distetica suplemento alimentar ou produto farmaceutico
BR0008879A (pt) Produto alimentìcio de animal de estimação, processo para preparar o mesmo, método para alimentar um animal, uso de fibra de endosperma de coco, e, métodos para a prevenção ou para o tratamento de uma infecção bacteriana patogênica no intestino grosso de um animal de estimação e de inflamação intestinal em um animal
CN103908423B (zh) 抗口腔幽门螺杆菌中药牙膏
GB0114672D0 (en) Pharmaceutical formulations and methods of medical treatment
GB2377638B (en) Treatment of infection in animals
Meheus Non-venereal treponematoses
Nividita Puri Holistic approach of oil pulling in the dental world A literature review
Lessard Discussion: nutritional aspects of oral health--new perspectives
DE60012521D1 (de) BAKTERIENSTAMM LACTOBACILLUS ACIDOPHILUS N.V. EP 317/402 NARINE, WELCHER ZUR HERSTELLUNG VON ZUSAMMENSETZUNGEN UND VON DIäTETISCHEN, THERAPEUTISCHEN UND PROPHYLAKTISCHEN PRODUKTEN ZUR BEHANDLUNG VON DYSBAKTERIOSE UND DEREN FOLGEN VERWENDET WIRD
ATE450267T1 (de) Verwendung von ginkgo biloba extrakten zur förderung der muskelmasse zum nachteil der fettmasse
JPH03112935A (ja) 溶血性連鎖球菌に対する生体内殺菌剤
BG105440A (en) Method and medicament for treatment of animals
RU94024117A (ru) Способ лечения гастроэнтероколита
CN1057172A (zh) 有指袜